{"id":"isis-apoc-iii-rx","safety":{"commonSideEffects":[{"rate":"10%","effect":"Nausea"},{"rate":"5%","effect":"Injection site reaction"},{"rate":"5%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL499450","moleculeType":"Small molecule","molecularWeight":"7343.20"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"ISIS apoC-III Rx is an antisense oligonucleotide that specifically targets apolipoprotein C-III (apoC-III) for degradation, thereby reducing triglyceride levels.","oneSentence":"Antisense oligonucleotide that targets apolipoprotein C-III","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:56:42.739Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertriglyceridemia"}]},"trialDetails":[{"nctId":"NCT01529424","phase":"PHASE2","title":"Safety, Tolerability, and Pharmacokinetic Study of ISIS ApoC-III Rx in Hypertriglyceridemia","status":"COMPLETED","sponsor":"Ionis Pharmaceuticals, Inc.","startDate":"2012-02","conditions":"Hypertriglyceridemia","enrollment":89}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"ISIS apoC-III Rx","genericName":"ISIS apoC-III Rx","companyName":"Ionis Pharmaceuticals, Inc.","companyId":"ionis-pharmaceuticals-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antisense oligonucleotide that targets apolipoprotein C-III Used for Hypertriglyceridemia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}